Lower Serum BCL-2 Protein Levels in Schizophrenia Patients Treated With the Second Than the First Generation Antipsychotics

Acta Medica Medianae
doi 10.5633/amm.2017.0420
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medical Faculty, University in Nis

Related search

Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics

American Journal of Psychiatry
PsychiatryMental Health
2003English

Pharmacogenetics and Cognitive Symptoms in Schizophrenia Patients Treated With Antipsychotics

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2018English

Serum Levels of Oxidants and Protein S100B Were Associated in the First-Episode Drug Naïve Patients With Schizophrenia

Global Clinical and Translational Research
2019English

59 Hazardous Lifestyles in Patients With Schizophrenia Treated With Antipsychotics: Results of the Bosnian Clinical Study

Acta Neuropsychiatrica
PsychiatryMental HealthBiological Psychiatry
2009English

Relationship Between the Timing of Relapse and Plasma Drug Levels Following Discontinuation of Cariprazine Treatment in Patients With Schizophrenia: Indirect Comparison With Other Second-Generation Antipsychotics After Treatment Discontinuation

Neuropsychiatric Disease and Treatment
2019English

Metabolic Monitoring of Psychiatric Patients on Second-Generation Antipsychotics

Annals of General Psychiatry
PsychiatryMental Health
2008English

The Effect of Second-Generation Antipsychotics on Hippocampal Volume in First Episode of Psychosis: Longitudinal Study

BJPsych Open
PsychiatryMental Health
2016English

Serum NCAM Levels and Cognitive Deficits in First Episode Schizophrenia Patients Versus Health Controls

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2018English

Erratum To: Suicidality and Second Generation Antipsychotics in Schizophrenia Patients: A Case-Controlled Retrospective Study During a 5-Year Period

Psychopharmacology
Pharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy